A nasal Proteosome™ influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity

This publication has 17 references indexed in Scilit:

• Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge
  Vaccine, 2001
• Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
  Vaccine, 2001
• Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine
  Vaccine, 1999
• Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice
  Vaccine, 1997
• Humoral and Cellular Immune Responses following Vaccination with Purified Recombinant Hemagglutinin from Influenza A (H3N2) Virus
  The Journal of Infectious Diseases, 1997
• Recombinant Baculovirus Influenza A Hemagglutinin Vaccines Are Well Tolerated and Immunogenic in Healthy Adults
  The Journal of Infectious Diseases, 1996
• Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells
  Archiv für die gesamte Virusforschung, 1996
• Evaluation of a Recombinant Hemagglutinin Expressed in Insect Cells as an Influenza Vaccine in Young and Elderly Adults
  The Journal of Infectious Diseases, 1996
• Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract
  Virus Research, 1992
• DETERMINANTS OF IMMUNITY TO INFLUENZA INFECTION IN MAN
  British Medical Bulletin, 1979